10:41 AM EST, 12/19/2024 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Thursday it appointed Kyle Rasbach as chief financial officer.
Rasbach was most recently working as chief business officer at Zentalis Pharmaceuticals ( ZNTL ) , according to the company.
Shares of Lexeo were down 4.4% in recent trading.
Price: 6.08, Change: -0.28, Percent Change: -4.40